144 related articles for article (PubMed ID: 37502840)
1. ACKR3-arrestin2/3 complexes reveal molecular consequences of GRK-dependent barcoding.
Chen Q; Schafer CT; Mukherjee S; Gustavsson M; Agrawal P; Yao XQ; Kossiakoff AA; Handel TM; Tesmer JJG
bioRxiv; 2023 Jul; ():. PubMed ID: 37502840
[TBL] [Abstract][Full Text] [Related]
2. Atypical Chemokine Receptor 3 "Senses" CXC Chemokine Receptor 4 Activation Through GPCR Kinase Phosphorylation.
Schafer CT; Chen Q; Tesmer JJG; Handel TM
Mol Pharmacol; 2023 Oct; 104(4):174-186. PubMed ID: 37474305
[TBL] [Abstract][Full Text] [Related]
3. Atypical Chemokine Receptor 3 'Senses' CXC Chemokine Receptor 4 Activation Through GPCR Kinase Phosphorylation.
Schafer CT; Chen Q; Tesmer JJG; Handel TM
bioRxiv; 2023 Mar; ():. PubMed ID: 36865154
[TBL] [Abstract][Full Text] [Related]
4. Differential Involvement of ACKR3 C-Tail in β-Arrestin Recruitment, Trafficking and Internalization.
Zarca A; Perez C; van den Bor J; Bebelman JP; Heuninck J; de Jonker RJF; Durroux T; Vischer HF; Siderius M; Smit MJ
Cells; 2021 Mar; 10(3):. PubMed ID: 33799570
[No Abstract] [Full Text] [Related]
5. Structures of atypical chemokine receptor 3 reveal the basis for its promiscuity and signaling bias.
Yen YC; Schafer CT; Gustavsson M; Eberle SA; Dominik PK; Deneka D; Zhang P; Schall TJ; Kossiakoff AA; Tesmer JJG; Handel TM
Sci Adv; 2022 Jul; 8(28):eabn8063. PubMed ID: 35857509
[TBL] [Abstract][Full Text] [Related]
6. CXCR7: a β-arrestin-biased receptor that potentiates cell migration and recruits β-arrestin2 exclusively through Gβγ subunits and GRK2.
Nguyen HT; Reyes-Alcaraz A; Yong HJ; Nguyen LP; Park HK; Inoue A; Lee CS; Seong JY; Hwang JI
Cell Biosci; 2020 Nov; 10(1):134. PubMed ID: 33292475
[TBL] [Abstract][Full Text] [Related]
7. ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin.
Saaber F; Schütz D; Miess E; Abe P; Desikan S; Ashok Kumar P; Balk S; Huang K; Beaulieu JM; Schulz S; Stumm R
Cell Rep; 2019 Feb; 26(6):1473-1488.e9. PubMed ID: 30726732
[TBL] [Abstract][Full Text] [Related]
8. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
Jaracz-Ros A; Bernadat G; Cutolo P; Gallego C; Gustavsson M; Cecon E; Baleux F; Kufareva I; Handel TM; Bachelerie F; Levoye A
J Leukoc Biol; 2020 Jun; 107(6):1123-1135. PubMed ID: 32374043
[TBL] [Abstract][Full Text] [Related]
9. GPCR kinase subtype requirements for arrestin-2 and -3 translocation to the cannabinoid CB
Manning JJ; Finlay DB; Glass M
Biochem Pharmacol; 2024 Jun; 224():116190. PubMed ID: 38604257
[TBL] [Abstract][Full Text] [Related]
10. Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
Benredjem B; Girard M; Rhainds D; St-Onge G; Heveker N
J Biol Chem; 2017 Jan; 292(1):31-42. PubMed ID: 27875312
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3.
Zarca AM; Adlere I; Viciano CP; Arimont-Segura M; Meyrath M; Simon IA; Bebelman JP; Laan D; Custers HGJ; Janssen E; Versteegh KL; Buzink MCML; Nesheva DN; Bosma R; de Esch IJP; Vischer HF; Wijtmans M; Szpakowska M; Chevigné A; Hoffmann C; de Graaf C; Zarzycka BA; Windhorst AD; Smit MJ; Leurs R
Mol Pharmacol; 2024 Mar; 105(4):301-312. PubMed ID: 38346795
[TBL] [Abstract][Full Text] [Related]
12. Effects of Small Molecule Ligands on ACKR3 Receptors.
Hopkins BE; Masuho I; Ren D; Iyamu ID; Lv W; Malik N; Martemyanov KA; Schiltz GE; Miller RJ
Mol Pharmacol; 2022 Sep; 102(3):128-138. PubMed ID: 35809897
[TBL] [Abstract][Full Text] [Related]
13. G protein-coupled receptor interactions with arrestins and GPCR kinases: The unresolved issue of signal bias.
Chen Q; Tesmer JJG
J Biol Chem; 2022 Sep; 298(9):102279. PubMed ID: 35863432
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding.
Gustavsson M; Dyer DP; Zhao C; Handel TM
Sci Signal; 2019 Sep; 12(598):. PubMed ID: 31506383
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of β
Nash CA; Nelson CP; Mistry R; Moeller-Olsen C; Christofidou E; Challiss RAJ; Willets JM
Cell Signal; 2018 Nov; 51():86-98. PubMed ID: 30075183
[TBL] [Abstract][Full Text] [Related]
16. Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed by Single-Molecule Analysis of their Conformational Landscapes.
Schafer CT; Pauszek Iii RF; Gustavsson M; Handel TM; Millar DP
bioRxiv; 2023 Nov; ():. PubMed ID: 37961571
[TBL] [Abstract][Full Text] [Related]
17. A complex structure of arrestin-2 bound to a G protein-coupled receptor.
Yin W; Li Z; Jin M; Yin YL; de Waal PW; Pal K; Yin Y; Gao X; He Y; Gao J; Wang X; Zhang Y; Zhou H; Melcher K; Jiang Y; Cong Y; Edward Zhou X; Yu X; Eric Xu H
Cell Res; 2019 Dec; 29(12):971-983. PubMed ID: 31776446
[TBL] [Abstract][Full Text] [Related]
18. Heterotrimeric Gq proteins act as a switch for GRK5/6 selectivity underlying β-arrestin transducer bias.
Kawakami K; Yanagawa M; Hiratsuka S; Yoshida M; Ono Y; Hiroshima M; Ueda M; Aoki J; Sako Y; Inoue A
Nat Commun; 2022 Jan; 13(1):487. PubMed ID: 35078997
[TBL] [Abstract][Full Text] [Related]
19. Ligand-specific conformational transitions and intracellular transport are required for atypical chemokine receptor 3-mediated chemokine scavenging.
Montpas N; St-Onge G; Nama N; Rhainds D; Benredjem B; Girard M; Hickson G; Pons V; Heveker N
J Biol Chem; 2018 Jan; 293(3):893-905. PubMed ID: 29180449
[TBL] [Abstract][Full Text] [Related]
20. Nanoluciferase-based complementation assay for systematic profiling of GPCR-GRK interactions.
Palmer CB; D'Uonnolo G; Luís R; Meyrath M; Uchański T; Chevigné A; Szpakowska M
Methods Cell Biol; 2022; 169():309-321. PubMed ID: 35623709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
